震の治療のためのボツリヌム毒素

Steven Bellows¹, Joseph Jankovic¹

¹Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

Toxins

|August 27, 2025

まとめ

ボトリヌム毒素 (BoNT) の注射は,基本的震やパーキンソン病を含む様々な震の治療に有望である. 効果的ですが,技術と結果を最適化するために,さらによく設計された試験が必要です.

科学分野:

神経科学
運動障害
薬理学について

背景:

震えは一般的な運動障害で治療方法は限られています
経口薬や脳深層刺激のような現在の治療には欠点があります
ボトリヌム毒素 (BoNT) はディストニアの治療に用いられているが,震の治療にはあまり研究されていない.

研究の目的:

ボトリヌム毒素 (BoNT) に関する証拠を検証する.
震治療におけるBoNTの効能と注射方法を評価する.
震に対する BoNT治療における研究のギャップを特定する.

主な方法:

ランダム化制御試験とオープンラベル試験のレビュー
主要な震え,パーキンソン病,頭,声,その他の震えにおけるBoNTの証拠の分析.
注射技術と結果の検討

主要な成果:

BoNTの注射は,いくつかの震症候群において有意な効果を示した.
エッセンシャル・トレーム,パーキンソン病のトレーム,頭部と声のトレームはポジティブな反応を示した.
筋肉の弱さは一般的な副作用です.

結論:

ボトリヌム毒素 (BoNT) は,様々な震えの原因に対する潜在的な治療法である.
標準化された方法によるさらなる高品質な研究が不可欠です.
BoNTプロトコルを最適化することで震え管理が改善できます

キーワード:

パーキンソン病ボトリンエレクトロミオグラフィーエッセンシャル・テーム毒素震える超音波検査

さらに関連する動画

07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

23.3K

12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.1K

関連する概念動画

01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

751

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

751

01:24

Parkinson's Disease: Treatment

376

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

376

01:20

Myasthenia Gravis: Overview and Treatment

1.9K

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

1.9K

01:31

Skeletal Muscle Relaxants: Therapeutic Uses

612

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

612

01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

840

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

840

01:28

Classification of Skeletal Muscle Relaxants

2.7K

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...